Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Crispin

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Nature Genetics|January 12, 2021
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infectionCornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, et al.
Cell Reports|April 7, 2021
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spikeRonald Derking, Joel D Allen, Christopher A Cottrell, et al.
NPJ Vaccines|August 20, 2025
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaquesPayal P Pratap, Christopher A Cottrell, James Quinn, et al.
Immunity|November 17, 2019
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of VulnerabilityViktoriya Dubrovskaya, Karen Tran, Gabriel Ozorowski, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 16, 2021
SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System SyndromeMarisol Perez-Toledo, Sian E Faustini, Sian E Jossi, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Immunology|May 1, 2021
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and salivaSian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infectionSian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Immunity|September 30, 2022
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursorsJordan R Willis, Zachary T Berndsen, Krystal M Ma, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Nature Genetics|January 12, 2021
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infectionCornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, et al.
Cell Reports|April 7, 2021
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spikeRonald Derking, Joel D Allen, Christopher A Cottrell, et al.
NPJ Vaccines|August 20, 2025
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaquesPayal P Pratap, Christopher A Cottrell, James Quinn, et al.
Immunity|November 17, 2019
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of VulnerabilityViktoriya Dubrovskaya, Karen Tran, Gabriel Ozorowski, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 16, 2021
SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System SyndromeMarisol Perez-Toledo, Sian E Faustini, Sian E Jossi, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Immunology|May 1, 2021
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and salivaSian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infectionSian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Immunity|September 30, 2022
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursorsJordan R Willis, Zachary T Berndsen, Krystal M Ma, et al.
Pageof 23